Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators..

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

2.

Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent Investigation (EASI).

Rothman M, Serruys P, Grollier G, Hoorntje J, van Den Bos A, Wijns W, Gershlick A, Van Es G, Melkert R, Eijgelshoven M, Lenderink T, Richardson G, Dille-Amo C; European Antiplatelet Stent Investigation..

Catheter Cardiovasc Interv. 2001 Feb;52(2):249-59.

PMID:
11170341

Supplemental Content

Loading ...
Support Center